Miami, FL, United States of America

Seung-Uon Shin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seung-Uon Shin: Innovator in Cancer Treatment

Introduction

Seung-Uon Shin is a prominent inventor based in Miami, FL (US), known for his significant contributions to the field of cancer treatment. With a focus on innovative therapeutic approaches, he has developed groundbreaking technologies that aim to improve patient outcomes.

Latest Patents

Seung-Uon Shin holds 2 patents that showcase his expertise in the development of novel fusion proteins. His latest patents include an "Antibody-endostatin fusion protein and its variants," which details methods for inhibiting tumor growth through the administration of chimeric fusion molecules. Additionally, he has developed "Compositions, methods and kits for treatment of cancer and autoimmune diseases," which focuses on fusion proteins that combine an IL-21 cytokine portion with an anti-CD20 antibody portion. These inventions provide valuable pharmaceutical compositions and kits that are particularly useful in treating cancer and autoimmune diseases.

Career Highlights

Seung-Uon Shin is affiliated with the University of Miami, where he continues to advance research in the field of oncology. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.

Collaborations

Throughout his career, Seung-Uon Shin has collaborated with esteemed colleagues, including Joseph David Rosenblatt and Sherie L Morrison. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Seung-Uon Shin's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…